A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

Clinical trial NCT05512208 · RECRUITING

Trial details

NCT number: NCT05512208
Sponsor: University of Oklahoma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrioid Cancer Mucinous Ovarian Cancer High Grade Serous Ovarian Cancer Cervical Cancer Solid Tumor

Start date: 2023-02-06
Primary completion: 2027-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.